Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana

Clicks: 715
ID: 110611
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Results from the first 3 years following RV1 introduction suggest substantial reductions of pediatric diarrheal disease as a result of vaccination. Our VE estimate is consistent with the observed rotavirus decrease and with efficacy estimates from elsewhere in sub-Saharan Africa.
Reference Key
g2016clinicalimpact Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Armah G;Pringle K;Enweronu-Laryea CC;Ansong D;Mwenda JM;Diamenu SK;Narh C;Lartey B;Binka F;Grytdal S;Patel M;Parashar U;Lopman B;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2016
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/27059357
Keywords
vaccination National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine logistic models research support non-u.s. gov't u.s. gov't female male Child Infant P.H.S. preschool Diarrhea / epidemiology diarrhea / prevention & control* pmid:27059357 doi:10.1093/cid/ciw014 george armah kimberly pringle ben lopman acute disease / epidemiology diarrhea / virology* epidemiological monitoring gastroenteritis / prevention & control gastroenteritis / virology ghana / epidemiology hospitalization immunization programs* immunization schedule* rotavirus infections / epidemiology rotavirus infections / prevention & control* rotavirus infections / virology rotavirus vaccines / administration & dosage rotavirus vaccines / immunology* vaccine potency vaccines attenuated / administration & dosage attenuated / immunology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.